Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Duration in Pseudomonas aeruginosa VAP (iDIAPASON)
NCT02634411Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Composite endpoint of Day-90 mortality and PA-VAP recurrence rate during hospitalization in the ICU. Started Jun 2016; status: completed.
02
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02634411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634411.